CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that management will be available for private
investor meetings at the 2010 Goldman Sachs Clean Energy Conference on
November 10, 2010 in New York City.
Interested parties who are institutional clients of Goldman Sachs should
contact Sam Gibbons of Metabolix Investor Relations at (203) 682-8351
for more information.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience
company focused on providing sustainable solutions for the world's needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is now
developing and commercializing Mirel™, a family of high performance
bioplastics which are biobased and biodegradable alternatives to many
petroleum-based plastics. Metabolix is also developing a proprietary
platform technology for co-producing plastics, chemicals and energy,
from crops such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com.
(MBLX-E)
Metabolix, Inc.
21 Erie Street
Cambridge, MA 02139
617-583-1700
or
Investor
Relations:
ICR
James Palczynski, 203-682-8229
jp@icrinc.com
Source: Metabolix, Inc.
News Provided by Acquire Media
